Lymphocyte number and stress parameter modifications in untreated breast cancer patients with depressive mood and previous life stress

Journal of Experimental Therapeutics and Oncology

Volumn 1, Issue 6, 1996, Pages 354-360

  Aragona, Marcello ^a,c   Muscatello, Maria R A ^a   Losi, Elena ^b   Panetta, Stefania ^a   La Torre, Francesco ^a   Pastura, Giuseppe ^b   Bertolani, Salvatore ^a   Mesiti, Mario ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE   (Italy)

Author keywords

Breast cancer; Catecholamines; Chronic stress; Depressive mood disorders; Diuresis; Lymphocytes

Indexed keywords

CATECHOLAMINE; HYDROCORTISONE;

ARTICLE; BLOOD; BREAST TUMOR; CLINICAL TRIAL; DEPRESSION; DIURESIS; FEMALE; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MENTAL STRESS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

BREAST NEOPLASMS; CATECHOLAMINES; DEPRESSION; DIURESIS; FEMALE; HUMANS; HYDROCORTISONE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL;

EID: 0030274634     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients: JAMA 249: 751-757, 1983.
2. Massie JM, Holland JC. Overview of normal reaction and prevalence of psychiatric disorders. In: Holland JC, Rowland H, (eds). Handbook of psycho-oncology. New York: Oxford University Press, 273-282, 1991.
3. Forsen A. Psychological stress as a risk for breast cancer. Psychother Psychosom 55: 176-185, 1991.
4. Geyer S. Situational effects in reporting life change events? A comparison of two assessment techniques. Psychotherapie Psychosomatik Medizinische Psychologie 42: 55-62, 1993.
5. Aragona M, Muscatello MRA, Mesiti M. Prevalence of depressive mood disorders in breast cancer patients of Southern Italy. Ann NY Acad Sci 784: 482-485, 1996.
6. Aragona M, Muscatello MRA, Mesiti M. Depressive mood disorders in patients with operable breast cancer. J Exp Clin Cancer Res 1996. (in press)
7. Aragona M. Eventi stressanti nella fase prodromica del carcinoma della mammella. Atti Accademia Peloritana dei Pericolanti 83: 1995. (in press)
8. Aragona M, Muscatello MRA, Pastura G, Castagnetta L, Mesiti M. Estrogen receptor and depressive mood disorders in untreated breast cancer patients. Oncol Rep 3: 661-665, 1996.
9. Aragona M, Aragona F. Chronic stress and histologic effects on the human central nervous system and other organs. Funct Neurol 9(3): 121-131, 1994.
10. Aragona M, Aragona F. Further studies of the chronic stress on the human central nervous system. 1996. Submitted for publication.
11. Tsigos C, Chrousos GP. Stress, endocrine manifestations, and diseases. In: Cooper CJ, (ed.). Stress, medicine, and health. New York: CRC press 61-85, 1996.
12. Dantzer R, Mormede P. Psychoneuroimmunology of stress. In: Leonard BE, Miller C, (eds). Stress, the immune system and psychiatry. Chichester: Wiley 47-67, 1995.
13. Leonard BE. Stress and the immune system: immunological aspects of depressive illness. In: Leonard BE, Miller C, (eds). Stress, the immune system and psychiatry. Chichester: Wiley 113-136, 1995.
14. Biondi M, Pancheri P. Clinical research strategies in psychoimmunology: a review of 46 human research studies (1972-1992). In: Leonard BE, Miller C, (eds). Stress, the immune system and psychiatry. Chichester: Wiley 85-111, 1995.
15. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 8942: 99, 1995.
16. Riley V. Psychoneuroendocrine influences on immuno-competence and neoplasia. Science 212: 1100-1109, 1981.
17. Ben-Eliyahu S, Yirmiya R, Liebeskind LC, Taylor AN, Gale RP. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun 5: 193-205, 1991.
18. Page GG, Ben-Eliyahu S, Liebeskind JC. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immun 8: 241-250, 1994.
19. Pancheri P. Stress emozioni e carcinogenesi. In: Pancheri P, Biondi M, (eds). Stress emozioni e cancro. Rome: Il Pensiero Scientifico ed. 1-22, 1987.
20. Biondi M, Conti C, Pancheri P, Sega FM, Sega E. Caratteristiche di personalità, meccanismi di difesa ed eventi esistenziali stressanti: confronto tra pazienti con carcinoma mammario e mastopatia fibrocistica. Rivista di Psichiatria 16: 271-282, 1981.
21. Carilli L, Gismondi R, Marconi PL, et al. Carcinoma dell'utero e calcolosi della colecisti: valutazioni psiconeuroendocrine nello stress preoperatorio. In: Pancheri P, Biondi M, (eds). Stress emozioni e cancro. Rome: Il pensiero scientifico ed. 63-94, 1987.
22. Yehuda R, Resnick H, Kahana B, Giller EL. Long-lasting hormonal alterations to extreme stress in humans: normative or maladaptive? Psychosom Med 55: 287-297, 1993.
23. Calogero AE, Norton JA, Sheppard BC, et al. Pulsatile activation of the hypothalamic-pituitary-arenal axis during major surgery. Metabolism 41(8): 839-845, 1992.
24. Selye H. Stress. Turin: Einaudi ed. 307-323, 1957.
25. Diagnostic and Statistical Manual of Mental Disorder III, Revised (DSM-III-R). Washington DC: American Psychiatric Association, 1987.
26. Verney EB. The antidiuretic hormone and the factors which determine its release. Proc Royal Soc Lond 135: 25, 1947.
27. Delrue-Perollet C, Li KS, Vitiello S, Neveu PJ. Peripheral catecholamines are involved in the neuroendocrine and immune effects of LPS. Brain Behav Immun 9: 149-162, 1995.
28. Rollnik JD, Mills PJ, Dimsdale JE. Characteristics of individuals who excrete versus retain sodium under stress. J Psychosom Res 39(4): 499-505, 1995.
29. Aragona M, Cardia G, Aragona F. Nuove acquisizioni sul significato dell'iperplasia dei centri germinativi del follicolo linfatico. Atti Accademia Peloritana dei Pericolanti. 80: 171-183, 1992.
30. Landmann R, Wesp M, Box R, Keller U, Bühler FR. Distribution and function of β-adrenergic receptors in human blood lymphocytes. In: Hadden JW, Mešek K, Nisticò G, (eds). Interactions among CNS, neuroendocrine and immune systems. Rome-Milan: Pythagora Press 251-264, 1989.
31. Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med 55: 364-379, 1993.
32. Madden KS, Ackerman KD, Livnat S, Felten SY, Felten DL. Neonatal sympathetic denervation alters development of natural killer (NK) cell activity in F344 rats. Brain Behav Immun 7: 344-351, 1993.
33. Dimsdale JE, Mills P, Patterson T, Ziegler M, Dillon E. Effect of chronic stress on beta-adrenergic receptor in the homeless. Psychosom Med 56: 290-295, 1994.
34. Gatti G, Masera RG, Pallavicini L, Sartori ML, Stuarenghi A, Orlandi F, Angeli A. Interplay in vitro between ACTH, β-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Brain Behav Immun 7: 16-28, 1993.
35. Aragona M, Cavaliere R, Panetta S, Ferlazzo G, Costa G, Adamo V. FCM detection of lymphocytic β-endorphin in cancer patients during hospitalization and after in vitro culture with IL2. Pharmacol Res 26(S2): 180-181, 1992.
36. Aragona M. L'ACTH intralinfocitario in pazienti con carcinoma della mammella: studio immunoistochimico e con citometria a flusso. Atti Accademia Peloritana dei Pericolanti 84: 1996. In press.
37. Sacerdote P, Manfredi B, Blanchi M, Panerai AE. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immun 8: 251-260, 1994.
38. Ciocca DR, Puy LA, Fasoli LC, et al. Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients. Breast Cancer Res Treat 15: 175-184, 1990.
39. Brosschot JF, Benschop RJ, Godaert GLR, Olff M, De Smet M, Heijnen CJ, Ballieux RE. Influence of life stress on immunological reactivity to mild psychological stress. Psychosom Med 56: 216-224, 1994.